For Healthcare professionals
outside the US
Why test for BRAF mutations?
Within these pages you’ll find information pertaining to prognostic factors in melanoma and evidence for characterizing BRAF+ melanoma as a distinct disease with a potentially worse prognosis than wild-type BRAF melanoma, including differentiating disease and patient characteristics.
